Risk of deep venous thrombosis associated with peripherally inserted central catheter: A retrospective cohort study of 11.588 catheters in Brazil
PLOS ONE · 06.05.2024 · 19 (5) · e0300425
DOI: 10.1371/journal.pone.0300425 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS ONE, online erschienen am 06.05.2024. Verfasst von Telma Christina do Campo Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department Nursing Specialized in Vascular Access, RN, MD. Hospital Sírio Libanês, São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Venous Thrombosis, Catheterization, Peripheral. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Deep Venous Thrombosis (DVT) due to Peripherally Inserted Central Catheter (PICC) is one of the most threatening complications after device insertion.
Objective
To assess the rate of PICC-associated DVT and analyze the risk factors associated with this event in cancer and critically ill patients.
Methods
We conducted a descriptive, retrospective cohort study with 11,588 PICCs from December 2014 to December 2019. Patients ≥ 18 years receiving a PICC were included. Pre-and post-puncture variables were collected and a logistic regression was used to identify the independent factors associated with the risk of DVT.
Results
The DVT prevalence was 1.8% (n = 213). The median length of PICC use was 15.3 days. The median age was 75 years (18; 107) and 52% were men, 53.5% were critically ill and 29.1% oncological patients. The most common indications for PICC’s were intravenous antibiotics (79.1%). Notably, 91.5% of PICC showed a catheter-to-vein ratio of no more than 33%. The tip location method with intracavitary electrocardiogram was used in 43%. Most catheters (67.9%) were electively removed at the end of intravenous therapy. After adjusting for cancer profile ou chemotherapy, regression anaysis revealed that age (OR 1.011; 95% CI 1.002–1.020), previous DVT (OR 1.96; 95% CI 1.12–3.44) and obstruction of the device (OR 1.60; 95% CI 1.05–2.42) were independent factors associated with PICC-associated DVT, whereas the use of an anticoagulant regimen was a protective variable (OR 0.73; 95% CI 0.54–0.99).
Conclusion
PICC is a safe and suitable intravenous device for medium and long-term therapy, with low rates of DVT even in a cohort of critically ill and cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department Nursing Specialized in Vascular Access, RN, MD. Hospital Sírio Libanês, São Paulo, São Paulo, Brazil.
- Adjunct Professor at the Federal University of Viçosa, RN, PhD. Viçosa, Minas Gerais, Brazil.
- Physician at the Dialysis Center, MD, PhD. Hospital Sírio Libanês, Nephrologist and Professor at Hospital das Clínicas of the University of São Paulo, São Paulo, São Paulo, Brazil.
ORCID-Profile: Telma Christina do Campo Silva
Zitieren
APA
Silva, T. C. D. C., Braga, L. M., & Vieira Junior, J. M. (2024). Risk of deep venous thrombosis associated with peripherally inserted central catheter: A retrospective cohort study of 11.588 catheters in Brazil. PLOS ONE, 19(5), e0300425. https://doi.org/10.1371/journal.pone.0300425
Vancouver
Silva TCDC, Braga LM, Vieira Junior JM. Risk of deep venous thrombosis associated with peripherally inserted central catheter: A retrospective cohort study of 11.588 catheters in Brazil. PLOS ONE. 2024;19(5):e0300425. doi:10.1371/journal.pone.0300425
BibTeX
@article{Silva2024,
author = {Silva, Telma Christina do Campo and Braga, Luciene Muniz and Vieira Junior, Jose Mauro},
title = {Risk of deep venous thrombosis associated with peripherally inserted central catheter: A retrospective cohort study of 11.588 catheters in Brazil},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {5},
pages = {e0300425},
doi = {10.1371/journal.pone.0300425}
}
EUVIMED